Order Article Reprints

Lee Y-Z, Hsu H-Y, Yang C-W, Lin Y-L, Chang S-Y, Yang R-B, Liang J-J, Chao T-L, Liao C-C, Kao H-C, et al. Correction: Lee et al. The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b. Pharmaceutics 2022, 14, 1511. Pharmaceutics. 2023; 15(2):342. https://doi.org/10.3390/pharmaceutics15020342

Lee, Yue-Zhi, Hsing-Yu Hsu, Cheng-Wei Yang, Yi-Ling Lin, Sui-Yuan Chang, Ruey-Bing Yang, Jian-Jong Liang, Tai-Ling Chao, Chun-Che Liao, Han-Chieh Kao, and et al. 2023. "Correction: Lee et al. The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b. Pharmaceutics 2022, 14, 1511" Pharmaceutics 15, no. 2: 342. https://doi.org/10.3390/pharmaceutics15020342

Lee, Y.-Z., Hsu, H.-Y., Yang, C.-W., Lin, Y.-L., Chang, S.-Y., Yang, R.-B., Liang, J.-J., Chao, T.-L., Liao, C.-C., Kao, H.-C., Chang, J.-Y., Sytwu, H.-K., Chen, C.-T., & Lee, S.-J. (2023). Correction: Lee et al. The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b. Pharmaceutics 2022, 14, 1511. Pharmaceutics, 15(2), 342. https://doi.org/10.3390/pharmaceutics15020342